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Abstract
MHC class II molecules (MHC II) play a pivotal role in the cell-surface presentation of antigens for surveillance by T cells.
Antigen loading takes place inside the cell in endosomal compartments and loss of the peptide ligand rapidly leads to the
formation of a non-receptive state of the MHC molecule. Non-receptiveness hinders the efficient loading of new antigens
onto the empty MHC II. However, the mechanisms driving the formation of the peptide inaccessible state are not well
understood. Here, a combined approach of experimental site-directed mutagenesis and computational modeling is used to
reveal structural features underlying ‘‘non-receptiveness.’’ Molecular dynamics simulations of the human MHC II HLA-DR1
suggest a straightening of the a-helix of the b1 domain during the transition from the open to the non-receptive state. The
movement is mostly confined to a hinge region conserved in all known MHC molecules. This shift causes a narrowing of the
two helices flanking the binding site and results in a closure, which is further stabilized by the formation of a critical
hydrogen bond between residues aQ9 and bN82. Mutagenesis experiments confirmed that replacement of either one of
the two residues by alanine renders the protein highly susceptible. Notably, loading enhancement was also observed when
the mutated MHC II molecules were expressed on the surface of fibroblast cells. Altogether, structural features underlying
the non-receptive state of empty HLA-DR1 identified by theoretical means and experiments revealed highly conserved
residues critically involved in the receptiveness of MHC II. The atomic details of rearrangements of the peptide-binding
groove upon peptide loss provide insight into structure and dynamics of empty MHC II molecules and may foster rational
approaches to interfere with non-receptiveness. Manipulation of peptide loading efficiency for improved peptide
vaccination strategies could be one of the applications profiting from the structural knowledge provided by this study.
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Introduction
Major histocompatibility complex molecules (MHC) display
protein fragments on the cell surface for the surveillance by T cells.
While class I MHC molecules present mainly peptides of
endogenous origin, the majority of the ligands of class II MHC
molecules (MHC II) derives from exogenous proteins. After
internalization into endosomal compartments these proteins are
proteolytically degraded into shorter fragments and loaded onto
MHC II molecules. The peptide/MHC II complexes are then
transported to the cell surface where they are displayed to CD4
+ T
cells that detect potential foreign antigens [1].
In the endosome the formation of stable peptide/MHC II
complexes is assisted by the chaperone HLA-DM [2]. By
interacting directly with the MHC II molecule the chaperone
stabilizes a ‘receptive’ conformation that allows rapid ligand
exchange. While this promotes binding of ligands with highest
affinity, a certain fraction of MHC molecules still looses its ligand
causing the appearance of ‘empty’ MHC II molecules on the cell-
surface [3]. In vitro data show that empty MHC II molecules
rapidly ‘inactivate’ by acquiring a ‘non-receptive’ conformation
[4]. This non-receptive state is characterized by the inability to
bind any free peptides and is presumably based on a closure of the
peptide binding cleft [4,5]. While on the one hand, this may
prevent ‘accidental’ loading of these molecules with peptides of the
extracellular space, it could also hamper efficient loading of APCs
during peptide vaccination.
Despite the fact that both the receptive and the non-receptive
states are kinetically well defined, their structures as well as the
underlying mechanism of inactivation is not known [6,7].
Numerous crystal structures have been solved for peptide-loaded
MHC II molecules but so far empty MHC II has resisted all
crystallization attempts. To gain insight into the structure of the
non-receptive MHC II conformer, we carried out molecular
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II molecule (HLA-DR1). The in silico model derived from these
calculations revealed a very defined conformation, in which
entrance to the peptide-binding site is blocked primarily by a shift
of the b1 a-helix. This helix adopts an energetically favored
extended conformation leading to a narrowing of the b1- and a1-
helix flanking the peptide-binding site. The concomitant groove
closure is stabilized by a newly formed H-bond network attaching
the conserved helix residue bN82 to residues located on the floor
of the binding site. Site-directed mutagenesis experiments of
soluble and cell surface MHC II confirmed that the integrity of this
‘lock’ is indeed crucial to maintain the non-receptive state.
Results
Molecular Dynamics (MD) simulations of ‘‘empty’’ MHC II
molecules
Extended molecular dynamics (MD) simulations of ‘empty’
HLA-DR1 molecules were carried out to identify characteristic
features of non-receptive MHC II molecules. ‘Empty’ starting
structures were generated from published X-ray crystal structures
by removing the peptide from the MHC binding site in silico. In
order to avoid computational bias resulting from crystal packaging
or from ligand-dependent side chain orientations, coordinates of
two different MHC II/ligand complexes were used (PBD entry
1DLH: HLA-DR1/HA306-318 [8] and 1SJE: HLA-DR1/
GAG166-181 [9]). To further improve the significance of the
calculation, between 2 and 5 independent simulations were
performed (Table 1). As reference for the non-receptive structure
MD simulations were also carried out with HLA-DR1 molecules
with a ligand-stabilized receptive conformation. In previous studies
we have shown that the occupation of the anchor pocket P1 by
small organic molecules such as AdEtOH (2-(1-adamantyl)ethanol)
[10] or short peptide fragments [11] maintains the receptive state
of the MHC molecule. Compounds exhibiting this effect had been
termed ‘MHC loading enhancer’ (MLE) [10] . For this study the
dipeptide Ac-FR-NH2, known to act as an MLE on HLA-DR1
molecules, was docked to the P1 pocket to generate model
structures representing the empty receptive state.
The MD simulations covered trajectories up to 30 ns. Based on
root mean square deviations (RMSD) this time frame was sufficient
for all ensembles to reach conformational stability (Fig. 1). The two
peptide-loaded HLA-DR1 ensembles (DR11DLH/HA306-318 and
DR11SJE/GAG166-181) as well as the P1-stabilized receptive form
(DR11DLH/Ac-FR-NH2) reached the equilibrium at ,5o r,10 ns,
respectively (Fig. 1A). A substantially slower equilibration was
observed for the two sets of empty MHC II molecules (DR11DLH
and DR11SJE); an effect caused by the higher flexibility of the
Table 1. Overview of the calculated MD-run ensembles.
name of run PDB entry of HLA-DR1 complex number of runs simulation time (ns)
DR11DLH/HA306-318 1DLH (with HA306-318 peptide) 2 15
‘empty’ DR11DLH 1DLH (without peptide) 5 30
DR11SJE/GAG166-181 1SJE (with GAG166-181 peptide) 2 15
‘empty’ DR11SJE 1SJE (without peptide) 4 30
DR11DLH/Ac-FR-NH2 receptive 1DLH (docked in silico with Ac-FR-NH2 MLE
compound)
31 5
doi:10.1371/journal.pone.0018662.t001
Figure 1. Root mean square deviations (RMSD) of the molecular dynamics (MD) simulations for the individual HLA-DR1 ensembles.
RMSD values for the a1/b1-domain are shown for the time course of the simulation. Different colors represent individual runs. A, The two peptide-
loaded structures DR11DLH/HA306-318 and DR11SJE/GAG166-181 (left panels) and the P1-stabilized dipeptide-loaded model DR11DLH/Ac-FR-NH2 were
calculated for 15 ns (right panel). B, Empty HLA-DR1-models derived from PDB entries 1DLH (DR11DLH empty) and 1SJE (DR11SJE empty) were
calculated for 30 ns.
doi:10.1371/journal.pone.0018662.g001
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conformational space the number of computational runs for the
empty forms was raised from 2 to 5.
While the two peptide-loaded structures showed RMSD values
of only 0.05 to 0.18 nm for the backbone, the two ‘empty’ HLA-
DR1 structures DR11DLH and DR11SJE showed a substantially
higher flexibility even after 10 ns equilibration time. Here, RMSD
values varied between 0.17 and 0.3 nm (Fig. 1B; overlays of frames
representing the start- and the equilibrated end-structure of all the
ensembles are depicted in supplementary Fig. S1). A heatmap of
the individual RMSD values plotted onto the MHC structure
revealed the RMSD variations to be mainly caused by movements
in the a-helices flanking the peptide-binding site (Fig. 2A). The
most striking differences between empty and loaded MHC
molecules were observed in the region b64–b77 of the b1 a-helix
(compare Fig. 2A, left and right panel). This segment is located
proximal to pocket P1 and ranges from a smaller kink in the a-
helix close to P1 to a prominent kink, present in all known MHC
molecules. While only very limited movements were observed in
the peptide loaded form (Fig. 2A, left panel), the P1-stabilzed form
showed a slightly increased flexibility (Fig. 2A, middle panel). This,
however, was mostly restricted to the helical regions located
distal to P1 but no substantial shifts were recorded in the region
b64–b77.
Distance measurements between the segments flanking the P1
pocket (a51–a61 and b73–b85) showed that the b64–b77-
movement caused a narrowing of the two opposing helix segments
which indeed resulted in a closure of the binding site (Fig. 2B and
supplementary Fig. S2 for the individual runs). The distribution of
observed distances for all simulated frames revealed a main
distance of only 1.1–1.3 nm for the empty HLA-DR1 molecule. In
contrast, in the peptide-loaded, as well as in the simulation of the
receptive P1-stabilized form, the majority of the frames exhibited a
significantly larger distance ranging from 1.4–1.6 nm.
Model of the non-receptive conformation
Graphic models of the MD-based transition to the non-
receptive state are depicted in figure 3. While the occupation of
Figure 2. Empty HLA-DR1 shows high mobility in the helices proximal to the P1 pocket. A, Color-coded view of the flexibility of the
antigen-binding site. The backbone structure of the peptide-binding site (a1/b1-domain) of HLA-DR1 is shown. In this orientation the upper a-helix is
formed by the a-chain, the lower a-helix by the b-chain, the N-terminus of the peptide ligand would point to the left side. The chains are colored as
heatmaps based on the RMSD of individual Ca-atoms from blue (small RMSD) to red (RMSD$6A ˚). The thickness of the backbone tube varies
accordingly (left panel, peptide loaded HLA-DR1 molecule; middle panel, the P1-stabilized receptive form; right panel, the empty form). For the
empty form, the hinge region (b64–77) showing the most extensive movement is indicated. B, Closure of peptide-binding site by helix segments
flanking the P1-pocket. The distance-distribution of the two helices flanking the P1-pocket (a51–61/b73–85) is shown for the average of the indicated
simulations. The distribution is shown for the empty HLA-DR1 (green, solid line), the peptide-loaded form (black, solid line), and the P1-stabilized
receptive form (black, dashed line).
doi:10.1371/journal.pone.0018662.g002
Controlling Receptiveness of Empty MHCII Molecules
PLoS ONE | www.plosone.org 3 April 2011 | Volume 6 | Issue 4 | e18662P1 by the MLE-dipeptide was sufficient to keep the binding site in
an open conformation (Fig. 3A, upper panels), a closure of the
binding site was observed in all equilibrated structures of the
empty molecule (Fig. 3A, lower panels). Notably however, this
closure was not caused by an uncontrolled collapse but rather due
to the acquisition of a defined conformational state. The
narrowing of the two flanking a-helices, caused mainly by
movements in the b64–b77 region, was driven by the acquisition
of an energetically favored extended conformation of the b1 a-
helix (Fig. 3A, lower panels). This translocation alone is fully
sufficient to block peptide entry to the binding site. The process,
however, was accompanied by rearrangements of residues inside
the binding cleft causing also the previously reported loss of the
important P1 anchor pocket [11].
Detailed analysis of the non-receptive frames further suggested
that the closed conformation was stabilized by a newly formed H-
bond network. An H-bond was formed between bN82 of the b1 a-
helix and residue aQ9 located proximal to P1 at the floor of the
peptide-binding site (Fig. 3B, left panels). In the peptide-loaded
complex both bN82 and aQ9 are involved in an intermolecular
H-bond network, attaching the backbone of the peptide ligand to
the binding site. After removal of the ligand both residues are
exposed to the solvent but quickly form an H-bond stabilizing the
extended conformation of the b1 helix segment that closes the
binding cleft. The distance-distribution plot for the side chain head
groups of bN82 and aQ9 (Fig. 3B, right panel) indicates that in the
simulations of the empty state the distance between the two
residues is consistent with an H-bond formation, suggesting that it
indeed functions as a ‘‘lock’’ for the closed conformation.
Experimental evidence for the conformational transi-
tions. To provide experimental evidence in support of the
postulated shift of the b1 a-helix segment, the non-receptive MHC
II structure was inspected for residues suitable for probing the
transition in mutagenesis experiments. aQ9 is located close to P1
on the floor of the peptide-binding site (Fig. 4A). In the peptide-
loaded as well as in the P1-stabilized receptive state the Ca-atom
of aQ9 is more than 10 A ˚ apart from the Ca-atom of bC79, as
suggested by MD simulations. This distance would be reduced to
about 6.6 A ˚ in the postulated non-receptive conformation,
sufficiently close to allow for the formation of an interdomain
disulfide bridge [12]. To determine if this bridge can actually be
formed, aQ9 was replaced by cysteine. To free bC79 for this
interaction its natural disulfide partner bC15 was replaced by
serine. After mutagenesis the protein was expressed in baculovirus-
infected insect cells and the formation of the interchain disulfide
bridge was analyzed in a Western blot by using HLA-DRab-
specific antibodies after SDS-PAGE (Fig. 4B).
As expected, two bands representing the individual a- and b-
monomers for both mutant and wt forms were detected when
separated under reducing conditions (Fig. 4B). Analogous bands
were also produced by the wild type under non-reducing
conditions. However, while dissociation of the two chains was
still observed under oxidizing conditions, a single band with a
MWapp of ,50 kDa, approximately double the size of the
monomeric a/b-chains (28 and 25 kDa, respectively) was detected
under non-reducing conditions for the mutated protein species.
Separate staining against the a- and the b-chain verified the
presence of both chains in the higher molecular weight band,
confirming that the complex is indeed representing a disulfide-
bridged a/b-heterodimer (data not shown).
Experimental evidence for the bN82-lock. To provide
experimental evidence for the importance of the bN82-lock for the
stability of the non-receptive state a number of mutations was
introduced into soluble HLA-DR1. The specific location of all
residues mutated in this study is depicted in supplementary Fig.
S3. The side chain positions are shown for both the receptive and
the non-receptive conformation suggested by the MD simulation.
Receptiveness of the mutated molecules was tested in an ELISA-
based peptide-loading assay using a biotinylated form of the
peptide antigen HA306-318 (bHA) (Fig. 5).
In the first series of experiments the two residues actually
forming the H-bond, bN82 and aQ9, were replaced by alanine. In
addition, bH81 was mutated to phenylalanine, an isosteric form of
histidine lacking the H-bond forming ability. Previous studies have
implicated the H-bond forming capacity of this residue to be
involved both in HLA-DM-mediated ligand release [13] as well as
in the stabilization of the closed MHC II conformation [14]. In
our model this residue is exposed to solvent and should therefore
not contribute to the stabilization of the non-receptive state.
Empty MHC II exists in two forms, the peptide-receptive and
the non-receptive state. The transition from the non-receptive to
the receptive state is rather slow so that the equilibrium between
both forms lies largely on the non-receptive side [4]. Thus, empty
MHC II is apparently ‘‘trapped’’ in the thermodynamically stable
non-receptive state and it is therefore not surprising that wt HLA-
DR1 showed rather inefficient peptide binding (Fig. 5, left panel).
The same, however, applied also to the bH81F mutant. In contrast
to a previous report [13] the absence of the H-bond provided by
bH81 had virtually no effect on the loading rate. Contrary to this,
however, aQ9A and bN82A clearly exhibited improved peptide-
loading capacity. Under the given experimental conditions,
comparable peptide loading was achieved at 10
2–10
3 times lower
peptide concentrations. The receptiveness of wt and bH81F could
be restored by the addition of P1-targeting MLE compounds.
AdEtOH [10] almost completely eliminated the differences in
peptide loading, showing that in principle all constructs were able
to acquire the receptive state (Fig. 5, right panel).
As mentioned before, the two residues bN82 and aQ9 involved
in the locking mechanism are also known to participate in direct
ligand interactions. This applies particularly to bN82, which forms
two H-bonds with the peptide backbone [8]. MHC II preparations
from baculovirus-infected cells as used for the above experiment
can contain endogenous ligands. To exclude that the observed
increase in loading efficiency of bN82- and aQ9-mutants is only
due to the accelerated release of prebound ligands, the
experiments were repeated with MHC II molecules produced in
E.coli (Fig. 6). Here, the a- and b-chain of the MHC molecule are
expressed independently followed by purification and refolding of
the empty MHC II molecule. E.coli HLA-DR1 is therefore almost
guaranteed to be devoid of any co-purified peptide ligands [15].
Moreover, to further consolidate our model by separating it from
previously published MD simulations two additional mutations
were included (bR71A and aE11A). Painter et al. [14] suggested
that non-receptiveness is largely due to the P1 blockage by an
unfolded a-helical segment, an effect not observed in our
simulation (see supplementary Fig. S3). bR71 has been suggested
as one of the key-residues stabilizing this blockage but does not
play a role in our model. aE11, in turn, has not been implicated in
the previous study but is assumed to have a strong indirect
influence on the stability of the postulated bN82-lock. While it
does not directly participate in the H-bond formation it closely
interacts with aD66 as well as aQ9 and is therefore expected to
have a profound impact on the electrostatics in this region [16].
When probing the receptiveness of empty E.coli-derived MHC II
molecules a similar picture emergedas itwas observed with material
derived from baculovirus-infected cells (compare Fig. 5). In ELISA-
based assays the most efficient peptide loading was detected with
bN82A followed by aQ9A and aE11A (Fig. 6A). Only a small effect
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PLoS ONE | www.plosone.org 4 April 2011 | Volume 6 | Issue 4 | e18662Figure 3. Structural model of the non-receptive conformation. A, Overview of structural changes in the antigen-binding site of the P1-
stabilized HLA-DR1 (upper panel) and the empty HLA-DR1 (lower panel). The starting structures for the MD simulations are shown in red, the stable
end frames of representative runs are shown in blue. The P1-stabilizing dipeptide FR [11], is indicated as yellow stick model. For empty HLA-DR1 the
approximate location of the P1-pocket is indicated with a circle. B, Stabilization of the closure of the antigen-binding site by the bN82/aQ9 H-bond.
The positions of aQ9 and bN82 are shown as yellow sticks. The left panels show close-up views of the postulated binding site structure proximal to
the P1-pocket. The region is shown in the receptive (red, left panel) and non-receptive state (blue, right panel). Formation of an H-bond is indicated
by a dashed line. Right panel: distribution plot for distances between the centers of the two carboxamides of aQ9 and bN82. Analysis was carried out
based on the MD simulations of the peptide-loaded (red line) and empty forms (black line). The distance plot reveals two maxima, with the maximum
at the smaller distance (,4.5 A ˚) being consistent with the formation of an H-bond.
doi:10.1371/journal.pone.0018662.g003
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baculovirus-derived material the addition of AdEtOH leveled out
the differences between the constructs by increasing the receptive-
ness of wt HLA-DR1, bH81F, and bR71A.
Similar differences in the receptiveness of the mutant forms
were also observed when the loading reaction was monitored by
fluorescence polarization (FP). This approach allows a precise
kinetic analysis since peptide loading can be recorded in real-time
(Fig. 6B, Table 2). Half-maximal loading (t1/2) required about 12 h
for the HLA-DR1 wt form, while less than 0.2 h was needed for
the bN82A mutant. aE11A and aQ9A also displayed significantly
decreased t1/2 (0.7 and 1.3 h, respectively) while bR71A and
bH81F required 15.5 and 5.5 h for half-maximal loading,
respectively. Thus, while for the latter two only marginal increases
were observed it translates into a 60fold faster loading reaction for
the bN82A mutant.
The mutations also affected the thermal stability of the MHC.
In a thermal shift assay (TSA) the integrity of the complex in
response to a raise in temperature was probed with SyproOrange.
The melting point of empty wt HLA-DR1 was determined as
,66uC. Removal of any of the residues assumed to be involved in
the bN82-lock led to a steep drop of thermal stability of more than
13 K (bN82A: 51uC, aQ9A: 52uC and aE11A: 52uC). The loss of
bR71and bH81, in contrast, resulted in a much smaller reduction
in thermal stability (bR71A, bH81A: 63uC). A similar result was
obtained, when the stability was analyzed by dynamic light
scattering (DLS). The elimination of any of the three residues
involved in the bN82-lock resulted in a significantly lowered
melting point as well, while only a marginal change was observed
for bH81F (Table 3).
The bN82-lock controls receptiveness on cell surface
MHC II molecules. To this point, all of our studies had been
Figure 4. Validation of the helical mobility by experimental introduction of an intermolecular disulfide bond. A, Postulated positions
of residues aQ9 and bC79 in the receptive and the non-receptive state. The backbone of the a- and the b-chain is shown in red (receptive) and blue
(non-receptive), respectively. The perspective is chosen to point into the binding cleft near the P1 pocket, with the b1 a-helix forming the right
boundary. Side chains are shown for residues aQ9 and bC79 as well as for bC15, naturally forming an intrachain disulfide bridge with bC79. The Ca-
distances are indicated. The receptive state is shown on the left side and the non-receptive state, characterized by a shift of the a-helix towards the
center of the cleft, on the right side. B, SDS-PAGE analysis of the aQ9C/bC15S mutant. Lysates of cells expressing either HLA-DR1 (wt) or the double
mutant aQ9C/bC15S (mut) were separated by SDS-PAGE under reducing (left panel) and non-reducing conditions (right panel). The detection of
bands representing either the single or the cross-linked a- and b-chains of HLA-DR1 was done by Western blot using polyclonal HLA-DR-specific
serum. Apparent molecular weight and positions of molecular weight markers (in kDa) are indicated.
doi:10.1371/journal.pone.0018662.g004
Figure 5. Influence of aQ9 and bN82 on the receptiveness of soluble HLA-DR1. ELISA-based antigen loading assays were carried out with
soluble forms of wt HLA-DR1 (black) and mutants aQ9A (magenta), bN82A (red), and bH81F (blue). MHC molecules derived from insect cells were
loaded with biotinylated peptide HA306-318. Loading was carried out in the absence (left panel) or presence (right panel) of the ‘MHC-loading
enhancer’ (MLE) compound AdEtOH [10]. The dashed line indicates the background in the absence of ligand.
doi:10.1371/journal.pone.0018662.g005
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and transmembrane regions. To determine whether the postulated
locking mechanism also controls receptiveness on the cell surface
HLA-DR1 wt and mutants were expressed as full length proteins
in murine fibroblast cells. In a FACS-based in vitro loading assay
[10] the cells were incubated with biotinylated HA306-318
peptide and the amount of peptide loaded onto the cells was
determined by flowcytometry after staining with fluorescence-
labeled streptavidin.
The histogram of the streptavidin staining revealed that only
low amounts of peptide can be loaded onto cells expressing the wt
MHC II (Fig. 7A, left panels). Substantially more peptide was
detected on cells expressing bN82A, aQ9A and aE11A, while
almost no increase was observed for bH81F and bR71A. The
differences are even more evident when comparing the loading
reactions for the different MHC variants in a dose-dependent way
(Fig. 7A, right panel). Mutations disrupting the proposed H-bond
network resulted in a 9fold increase for bN82A and a 4–5fold
increase for aQ9A and aE11A. In contrast bH81F and bR71A-
mutations did not significantly affect peptide binding. As shown
before for soluble MHC II, functionality of all mutants was verified
by addition of AdEtOH (Fig. 7B). Thus, the bN82-lock seems to
be functional also on the cell-bound form of MHC II and
disrupting this lock leads to an increased loading efficiency of
antigens. Subsequently, the higher peptide/MHC density on the
cell surface is likely to enhance the T cell response. This
particularly applies at lower antigen concentrations.
Discussion
The study strongly suggests that the receptive as well as the non-
receptive state of empty class II MHC molecules are based on
conformation with very distinct structural features. The in silico
analysis of a molecular dynamics simulation of empty MHC II
indicates that the closure of the binding site is likely being caused
by defined structural transitions, namely the extension of the b1 a-
helix at a prominent kink near residues b70–75. The narrowing of
the two helices flanking the peptide-binding region results in a
closure of the site, a conformational shift, stabilized by the
formation of an H-bond lock involving the conserved helix residue
bN82. While the models derived from MD simulations identified
single residues governing the inactivation of MHC II, we could
also provide experimental evidence that the mutation of key
residues identified by the in silico approach strongly affects the
Figure 6. Analysis of aQ9/bN82-interaction with DR1 produced in E.coli.A , ELISA-based peptide loading assay. Empty, soluble HLA-DR1
molecules refolded from material produced in E.coli were used in an ELISA-based antigen loading experiment as described in Fig. 5. wt HLA-DR1
(black), aQ9A (magenta), aE11A (green), bR71A (light blue), bH81F (dark blue) and bN82A (red) were loaded with biotinylated HA306-318. Loading
was carried out in the absence (left panel) or presence (right panel) of the MLE-compound AdEtOH. B, Kinetic analysis of antigen-loading monitored
by fluorescence polarization. wt and mutant forms of HLA-DR1 were loaded with a fluorescence-labeled variant of HA306-318. Loading was
monitored in real time by measuring the change in fluorescence polarization. The data normalized to maximum loading were fitted to a single
exponential binding function [42].
doi:10.1371/journal.pone.0018662.g006
Table 2. Loading rates and half-maximal loading time of
HLA-DR1 variants loaded with HA306-318 as determined by
fluorescence polarization.
HLA-DR1 rate [1/h] t1/2 [h]
wt 0.0660.01 12.263.0
aQ9A 0.5460.05 1.360.1
aE11A 1.0560.1 0.760.1
bR71A 0.0760.01 15.561.6
bH81F 0.1360.02 5.560.9
bN82A 3.8360.66 0.260.03
doi:10.1371/journal.pone.0018662.t002
Table 3. Melting points of empty HLA-DR1 variants as
determined by thermal shift assay (TSA) and dynamic light
scattering (DLS).
HLA-DR1 Tm [6C] by TSA Tm [6C] by DLS
wt 66.460.5 71.5
aQ9A 52.260.3 55
aE11A 51.860.2 55.3
bR71A 62.960.8 n.d.*
bH81F 62.560.4 65.5
bN82A 51.360.1 51.1
*) not determined.
doi:10.1371/journal.pone.0018662.t003
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Kinetically differentiable forms of empty MHC II are well
known [4,5,16] and structural alterations in the conformation have
been made responsible for the apparent differences between
receptive and non-receptive forms [6,7]. However, despite several
attempts to reveal the conformational changes [6,17,18] the
precise nature of the underlying structural change has remained
elusive. As direct structural data is lacking, molecular dynamics
simulation has recently been applied as an alternative to gain some
insight into the structural dynamics of empty MHC II [11,14,19].
Several models have been proposed. Painter et al. suggested that
the non-receptive state is characterized by partial unfolding of the
a1-helix [14]. This unfolded segment occupies the binding site,
stabilized by H-bond interactions with a set of residues (aQ9,
bR71, bH81, and bN82), in a fashion closely resembling peptide
binding. In initial MD simulations partial unfolding was also
observed by Yaneva et al. [19]. This, however, could be corrected
by computational adjustment of the protonation state of the
starting structure. Similarly, our own simulations did not produce
any evidence for the postulated a-helix unfolding. The integrity of
secondary structure elements was maintained during the simula-
tion. Moreover, mutagenesis of two residues involved in the
stabilization of the unfolded complex (bH81 and bR71) did not
reveal any influence on the receptiveness of the empty MHC
molecule (Fig. 6). This applies in particular to bH81 which had
even been suggested by others to be the key-factor in controlling
the ligand exchange rate [13]. In addition to inconsistence with the
data presented in this study, two other recent studies also indicate
Figure 7. Influence of the putative bN82-lock on the receptiveness of cell surface MHC II. A, Surface loading of HLA-DR1-expressing
fibroblast cells. Full-length forms of wt and mutant HLA-DR1 were expressed in L929 fibroblast cells. In an in vitro loading assay [10], cells were
incubated for 4 h with biotin-labeled HA306-318. Cell-surface loading of HLA-DR1 with peptide was analyzed by FACS after staining with APC-
streptavidin. Representative histogram plots (right panels) are shown depicting the fluorescence recorded in the absence (grey) or presence of the
biotinylated HA306-318 peptide (black). Dose response curves for titrated amounts of the peptide are shown in the right panels for wt HLA-DR1
(black), aQ9A (magenta), aE11A (green), bR71A (light blue), bH81F (dark blue), and bN82A (red). B, Cell surface loading in the presence of MLE. The
same experiments as described in Fig. 6A were carried out in presence of the MLE compound AdEtOH.
doi:10.1371/journal.pone.0018662.g007
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[20,21].
Our data instead support a model in which the transition from
the receptive to the non-receptive state is more subtle and
characterized only by defined shifts of conserved secondary
structure elements. Central to this is the shift of the b1-helix
resulting in a closure of the binding cleft. This shift is accompanied
by a loss of the P1 pocket, mainly as a consequence of a
rearrangement of other residues in the binding site. The
movement is largely confined to the b64–b77 segment leading
from a bend conformation to the acquisition of an energetically
favored extended conformation. Notably, this straightening of the
helix is not observed when the P1 pocket is filled by a short
dipeptide. The open conformation reported here and in a previous
simulation [11] was also observed by Yaneva et al. in an MD
simulation of HLA-DR3 loaded with a dipeptidic CLIP fragment
[19].
As an important structural feature the MD simulation suggested
an H-bond lock in which the conserved helix residue bN82 forms
a bridge with aQ9. The H-bond seems to stabilize the closed
conformation by fixing the extended b1 a-helix to the floor of the
empty binding site. Experimental evidence provided by the
mutational analysis of HLA-DR1 confirmed that these residues
play indeed a significant role for the stability of the non-receptive
state. Ablation of this interaction led to empty MHC molecules
with a highly increased peptide-loading efficiency. This applied
both to truncated soluble molecules as well as to membrane-
bound, full length MHC. A similar enhancement was also
observed for aE11, a residue located proximal to aQ9 interacting
with aD66 of the a1 a-helix. The residue is expected to modulate
the strength of the aQ9/bN82 bridge by electrostatic interaction.
Interestingly, one report already discussed the potential influence
of the aE11/D66-cluster in I-E
k as being responsible for a
conformational change from a peptide-exchange-susceptible to a
stable, exchange-insusceptible peptide/MHC-conformer [22].
The impact of single MHC II residues on the overall stability of
peptide/MHC complexes is well known. Respective interactions
were demonstrated for the murine MHC II molecules I-A
d
[23,24,25] and I-E
k [26] as well as for human HLA-DR1 [13,27].
Also in these studies the effect has been attributed to the particular
contributions to a conserved hydrogen network that particularly
applies to bN82. The mutation of bN82 to serine has a profound
influence on peptide-MHC stability as was shown for I-E
d and I-
A
d [28,29] and the transport of nascent MHC to the cell surface
was also affected by this mutation [30]. Central to these previous
studies was the H-bond formed between bN82 and the peptide
ligand. The data presented here, however suggest that internal H-
bonds formed by bN82 and residues on the floor of the binding
site may play an equally crucial role in maintaining conforma-
tional stability of the empty molecule. Utilizing ‘truly’ empty
MHC II derived from E.coli we were able to show that interference
with the proposed lock significantly reduced the thermal stability
of the empty MHC II. Moreover, the empty MHC II from E.coli
preparations also enabled us to analyze the peptide loading of
empty MHC II devoid of any pre-bound ligands. Clearly, with
these preparations the high impact of the bN82 lock on the
loading efficiency of MHC II could be reproduced. Thus, the H-
bond donor function of bN82 seems to be crucial for both fixing
the ligand on the MHC molecule and closing the empty binding
cleft.
Importantly, the proposed locking mechanism was also detected
on membrane-bound MHC II. Loading rate and efficiency were
affected by mutations in the same way as for the soluble MHC II.
From an immunological point of view the transition from a
receptive to a non-receptive state could function as a safeguard
mechanism that prevents uncontrolled binding of antigens to
empty MHC. Empty, peptide-receptive MHC on the cell surface
of an antigen-presenting cell (APC) could bind any suitable antigen
from the extracellular milieu. In fact, capture of extracellular
antigens by immature dendritic cells has been suggested to be an
alternative pathway with particular relevance for tolerance
induction [3,31,32]. However, as it bypasses defined uptake
mechanisms, such as Fc-receptor- or scavenger receptor-mediated
antigen uptake it might also lead to the induction of unwanted
inflammatory responses. Notably, the group of Unanue showed
that the route of antigen presentation can even allow to address
different types of T cells. Type A T cells responded to antigens
when they were delivered to the MHC molecule after uptake via
the endosomal pathway, while Type B T cells responded only to
peptides directly loaded onto the MHC [33]. The reason for this
‘‘peptide isomerism’’ is still unknown. It may have conformational
causes but might also be due to different orientations of the ligand
[33,34]. Recently they could show that in the Non-Obese Diabetic
(NOD)-mouse model both T cell types can be found in
diabetogenic mice. Moreover, type B T cells were able to induce
diabetes upon adoptive transfer [35].
In summary, we could define discrete conformational states
corresponding to the well described kinetic states of empty MHC
II. While this model describes ‘non-receptiveness’ in a conclusive
way, it may not reflect the end-point of conformational change.
However, with bN82, aQ9 and aE11 we identified a set of
residues close to the P1 pocket that greatly affects the stability of
the non-receptive state presumably by locking the empty MHC
molecule by an internal H-bond network. While the acquisition of
this non-receptive state may serve as natural safeguard mechanism
to prevent autoimmune reactions, in the context of peptide
vaccinations it can strongly abrogate effective antigen loading.
Understanding the structural basis of the transition may therefore
not only provide insight on dynamics and function of MHC-
conformers, it may also provide new molecular targets to improve
the efficiency of immune interventions.
Materials and Methods
Molecular Dynamics simulations
For each ensemble used in the simulation (the empty MHC
structure, the MHC-antigen complex, and the Ac-FR-NH2 in
complex with the MHC) a 15 or 30 ns molecular dynamics
simulation was performed using the GROMACS software package
with the GROMOS force field (ffG43a1) [36]. The proteins were
placed into a triclinic box which is 39% smaller than a rectangular
system. The simulations were done under physiological conditions.
For this purpose the structures of the proteins and of the ligand
complexes were calculated in a 0.9% NaCl (e.g. ,12700 Spc H2O
molecules, 70 Na
+- and 60 Cl
2-ions, respectively) solution at
310 K and periodic boundary conditions for the box. Short range
non-bonded interactions were calculated with the cut-off Lennard-
Jones potential up to a distance of 1.2 nm between the interacting
atoms. For long range electrostatic interactions the particle mesh
Ewald (PME) option was used with a grid spacing of 0.12 nm. The
bond length of a heavy atom to a hydrogen atom in protein or
water was constrained using the LINCS and SETTLE algorithm,
respectively. Each simulation ensemble was energy minimized in a
two step minimization strategy. In a first step steepest descent and
in a second a conjugate gradient minimizing routine was used.
After equilibration over a period of 500 ps using a positional
restraint of 1000 kJmol
21 nm
22 on the backbone of the protein
and, if present, on the ligand, a free simulation was performed for
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MHC. Temperature and pressure (1 bar) were controlled using
the Berendsen coupling with a relaxation time of 0.1 ps for
temperature and 1 ps for pressure. During the course of the
simulation, a frame was stored every 5 ps. Visualization of
trajectories and arrangement of the figures were realized using
VMD [37] and PyMOL (DeLano Scientific, California, USA).
Generation of MHC molecules
Soluble HLA-DR1 was expressed in a baculovirus-based system
or by refolding from E.coli. The insect cell derived MHC was
expressed essentially as described before [11]. Briefly, for the insect
cell derived protein DNA coding for the extracellular domains of
DRA*0101 and DRB1*0101 was cloned into the transfer vector
pFastbac 1 (Invitrogen). Leucine zipper domains were added to
the C-termini of the a- and b-chain, as described [38]. Site-
directed mutagenesis of HLA-DR1 was carried out using the
QuikChange site-directed mutagenesis kit (Stratagene). Recombi-
nant viruses were generated in S.frugiperda cells (Sf21). For
expression of proteins, cells were co-infected with viruses for the
a- and b-chain. Soluble HLA-DR1 was purified from the culture
supernatant by affinity chromatography with the HLA-DR
specific antibody LB3.1 as described [39].
Soluble HLA-DR1 from E.coli was refolded from inclusion
bodies as described previously [40] in a method adapted from
Stern and colleagues [15]. The ectodomains of the a- and b-chain
were expressed separately as inclusion bodies. After purification of
the single chains, both denatured chains were combined and
refolded together by dilution. Correctly refolded MHC was further
purified as described above.
Western blot analysis of cross-linked HLA-DR1
For cross-linking experiments HLA-DR1 variants without
additional leucine zippers were expressed in baculovirus-infected
Sf21 cells. Cells were harvested 72 h postinfection and lysed in a
buffer containing 50 mM Tris, pH 8.0, 150 mM NaCl, 1% NP40,
and 20 mM NEM. For reduction of samples 100 mM dithiothre-
itol was added. 1 mg total protein per lane was separated on a 12%
SDS-PAGE and subsequently transferred to a polyvinyldifluoride
membrane (Immobilon P, Millipore, USA). MHC was detected
with a rabbit serum raised against the HLA-DRa- and b-chain as
described [41].
Peptide binding to soluble HLA-DR1
The peptide-binding ability of the different HLA-DR1
variants was evaluated by an ELISA-based assay [10]. Briefly,
100 nM soluble HLA-DR1 from E.coli or insect cells were
incubated with increasing amounts of biotinylated HA306-318
for 30 min resp. 2 h at 37uC. Afterwards the amount of peptide-
loaded MHC was assessed by a DELFIA-based ELISA with the
HLA-DR-specific capture antibody L243 and Eu
3+-labeled
streptavidin. The plates were read in a Victor 3V reader (Perkin
Elmer). Curves were fitted to a four-parameter logistic function
with the SigmaPlot11 (Systat Software Inc.) software. Loading
rates of the empty HLA-DR1 variants were determined with a
fluorescence polarization assay. In a total reaction volume of
40 mL1 mM HLA-DR1 was incubated with 100 nM FITC-
labeled HA306-318 in a non-binding black microplate (Corning).
Measurements were conducted in a Victor 3V reader at 37uC. In
between measurements the plate was kept in the dark at 37uC.
Data points were fitted to a monomodal association model
[FP=FPmax(1-e
2kt)] [42], where k is the observed rate constant
at the given concentration.
Peptide binding to full length cell-surface HLA-DR1
Murine fibroblast cells L929 were transfected with two
pcDNA3.1 vectors containing the full length HLA-DR1 a- resp.
b-chain coding sequences for transient expression of the MHC.
The loading experiments were carried out 4 days after
transfection. Therefore, 10
5 cells/well were incubated with
increasing amounts of biotinylated HA306-318 (4 h, 37uC,
DMEM, 5% FCS). For FACS-analysis cells were stained with
streptavidin-PE and analyzed on a FACScalibur instrument (BD
Biosciences) as described [10]. Dead cells were excluded by
propidium iodide staining. To compensate for the variability in
cell-surface expression levels of different transfections cells
expressing the different HLA-DR1 variants were gated on a
uniform MHC II surface expression level by staining with L243-
FITC.
Thermal stability
For determining the thermal stability of the HLA-DR1 variants
a thermofluor assay was used [43]. In the fluorescence-based assay
24 ml of a 0.2–0.4 mg/mL gel filtrated sample were transferred to
a microtiter plate (ABGene), mixed with 1 mL 1256SyproOrange
(Molecular Probes, Invitrogen) and measured in an iCycler iQ
Real Time Detection System (Bio-Rad), using steps of 1uC from
20uCt o9 9 uC. This dye responds to altered chemical environ-
ments by a shift in its fluorescence spectrum. Fluorescence
intensity curves were plotted versus temperature and midpoints
of the protein unfolding transition (Tm) were determined by fitting
a sigmoidal curve to the data. The transition points of the
fluorescence intensity over time were defined as Tm.T m-values are
the mean values from at least two independent experiments
conducted in duplicate. Dynamic light scattering measurements
were carried out in the Zeta Nanosizer ZS (Malvern, UK). 50 mL
of freshly gel filtrated sample at 1 mM were slowly heated from 25
to 91uC (by three degrees steps from 20 to 46 and two-degrees
steps to 90uC). After 10 min equilibration time the samples were
measured five times for one minute and the values were averaged.
According to manufacturer’s recommendation the melting point of
the sample was determined by plotting the particle size of the main
fraction against the temperature and defined as the point of
significant increase with irreversible particle sizes after recooling of
the sample to 25uC
Supporting Information
Figure S1 Antigen-binding site is closing in the absence
of P1-occupation. The structure of the antigen-binding site of
HLA-DR1 in representative frames of the MD simulations is
shown. The starting structure is in red, the equilibrated end
structure in blue. A, Comparison of peptide-loaded (left) and
peptide-free (right) simulations of both crystal structures used in
this study (1DLH upper panel, 1SJE, lower panel). B, Occupation
of P1-pocket by the dipeptide leads to stabilization of the whole
antigen-binding site during MD.
(TIF)
Figure S2 Distance of the helical regions flanking the
P1-Pocket. The distance distribution for each individual MD
simulation is shown. The distance was measured between the
centers of mass of the a-helical regions flanking the P1-pocket
(a51–61 and b73–85). The different starting structures are
indicated in the graphs, the individual runs are shown in different
colors. The distance distribution for the replicated runs is
comparable. Only in one out of nine runs with empty HLA-
DR1 a very narrow distance was reached (DR11DLHempty, black
line, upper left panel). Visual inspection of the corresponding MD
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PLoS ONE | www.plosone.org 10 April 2011 | Volume 6 | Issue 4 | e18662simulation reveals in this case a drastic inwards motion of the b-
chain a-helix resulting in a collapsed antigen-binding site. The
significance of this singular event, however, is not clear.
(TIF)
Figure S3 Position of residues used for introduction of
point mutations to probe the putative locking mecha-
nism. The amino acids are shown as yellow sticks. Left, open
binding site at the beginning of the MD simulations. Right, closed
binding site of the equilibrated closed structure of empty MHC II.
aQ9 and bN82 are forming an H-bond (black dashed line).
Residues bR71 and bH81 are apparently not involved in the
stabilization of the non-receptive structure.
(TIF)
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